Tools chosen: kalshi_direct kalshi_related polymarket_related claude_news gdelt_news congress_bills wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a long-dated Kalshi political/trade question requiring a formal free trade agreement with China enacted into US law before Jan 20, 2029 — an extremely high bar historically (no FTA with China has ever existed; even the 2020 Phase One deal was an executive agreement, not implementing legislation). The key research is the current Kalshi price anchor, the state of US-China trade negotiations/truce, and the base rate for US FTAs becoming law under any administration.

# Current state The market resolves YES only if a US-China free trade agreement becomes law via Senate ratification or Congressional-Executive Agreement with implementing legislation before Jan 20, 2029 — a high legal bar. Currently there is no FTA, no implementing legislation pending, and US-China relations remain governed by a fragile, executive-only tariff truce (not a treaty), with underlying Section 301/IEEPA tariffs still in place. # Timeline of key events - 2018–2019: US-China trade war escalates; Section 301 tariffs imposed on ~$300B of Chinese goods (confirmed, Wikipedia). - 2020-01: Phase One deal signed as a **purely executive agreement**, not submitted to Congress for approval per USTR Lighthizer statement (confirmed, claude_news/Politico). - 2025 (through year): Tariff war re-escalates under second Trump term; US tariffs on China peak near 145%, China retaliates to 125% (confirmed, Wikipedia). - 2025-10-30: Trump-Xi summit in Busan (APEC) produces a **one-year trade truce** — tariff cut 57%→47%, China pauses rare-earth export controls, soybean purchase commitments; explicitly not a comprehensive deal (confirmed, Al Jazeera/Brookings/CFR). - 2025-12-18: Senate bill "No Trade Preferences for Communist China Act" (S.3566) introduced, referred to Finance Committee — signals congressional appetite runs toward restricting, not liberalizing, China trade (confirmed, congress.gov). - 2026-05-20: Trump visit to Beijing; sides discuss restoring some tariffs and a narrow "Board of Trade" covering ~$30B in noncritical goods, but no truce extension agreed yet (reported, freightamigo/PwC). - 2026-07 to 2026-08: Renewed friction — China protests new US tariffs (forced-labor related), commentary that "this wave of tariffs is likely here to stay," and reports Trump may get broad unilateral tariff authority via pending legislation (reported, GDELT/Newsweek/Fortune). # Event Will a US-China free trade agreement (via Senate ratification or Congressional-Executive Agreement + implementing legislation) become law before Jan 20, 2029? # Outcomes to forecast Yes / No # Kalshi market anchor **Current YES price: 15%** (down from a 30-day-ago level implying a 14-point drop; price range over 59 days: 15%–43%). 7-day change flat (+0%). Average daily volume: 108 contracts (moderate liquidity). Price has trended sharply downward from a much higher earlier level toward the current 15% floor — market has repriced away from any comprehensive deal. # Sub-question answers 1. **Kalshi price/trend** — 15% currently; fell 14 points over 30 days from a high of 43%; volume ~108/day (kalshi_direct). 2. **Current negotiation status** — No comprehensive deal exists or is being negotiated; only a fragile one-year tariff truce (Oct 2025 Busan) plus a narrow "Board of Trade" concept covering $30B in goods discussed May 2026; analysts (Brookings, Coface) call it a "tactical truce," not a strategic deal (claude_news). 3. **FTA base rate** — ~14 US FTAs enacted since 1985 (~0.35/year); expected ~1.1 new FTAs of any kind in the remaining window, but zero precedent for an FTA with a large non-market economy like China (code_execution). 4. **Phase One precedent** — Purely an executive agreement; USTR Lighthizer explicitly stated no intent to submit it to Congress (claude_news/Politico). Since 2011, only USMCA has been a congressionally-approved FTA — no precedent for China-style deal going through Congress. 5. **Tariff posture** — Escalatory/adversarial: Section 301 tariffs (~$300B in imports) remain entrenched as permanent policy ("high fence, small yard"); new forced-labor tariffs imposed mid-2026; Trump reportedly seeking expanded unilateral tariff authority (claude_news/GDELT). 6. **Congressional appetite** — Bills trend toward restricting China trade (S.3566 "No Trade Preferences for Communist China Act," Dec 2025) rather than liberalizing it; no PNTR-restoration or FTA-enabling bill found (congress_bills). # Key facts (high-confidence, factual) 1. [kalshi_direct] YES price 15%, down from 43% high, 108 avg daily volume. 2. [claude_news] Oct 2025 Busan truce is one-year, non-comprehensive, executive-only. 3. [claude_news] Phase One (2020) was never submitted to Congress; established pattern. 4. [congress_bills] Recent Senate bill seeks to strip China's trade preferences, not grant new ones. 5. [Wikipedia] Section 301 tariffs remain in place since 2018, still ~$300B in scope. 6. [code_execution] Zero historical FTAs with large non-market economies (0/14 since 1985). # Cross-market signals - Kalshi related: "Will the U.S. enact a free trade agreement? — Before 2029" (any partner) priced at 38% — much higher than China-specific 15%, confirming markets see China as a much harder case than FTAs generally. - Polymarket: No matching markets found (polymarket_related) — no cross-check available. - Sportsbook implied: N/A (not a sports/political-odds market type). # Analyst opinions and speculation - Brookings/Coface: truce is "shallow," "fragile," unlikely to evolve into durable comprehensive deal; semiconductors/rare earths remain unresolved flashpoints. - CFR/PwC: expect more truces/purchase commitments, not formal FTA. - code_execution model: point estimate 0.5–1% for a "genuine" congressionally-enacted FTA; up to 5–15% if resolution criteria are loosely interpreted to include narrower agreements — but the question's rules explicitly require law via ratification/implementing legislation, which argues for the strict low end. # Directional lean per outcome - **Yes**: Weak support — Trump has demonstrated dealmaking willingness (Busan truce, Beijing visit); some incremental "Board of Trade" concept floated. But no evidence of intent to pursue congressional ratification; structural/legal bar is very high. - **No**: Strong support — zero historical precedent for FTA with a non-market economy, established Trump-era pattern of executive-only agreements (not needing/seeking congressional approval), current tariff escalation (not liberalization), congressional bills trending toward restricting China trade, and Kalshi price already down to 15% and falling. # Gaps / unknowns - No visibility into any secret negotiation track that might target actual implementing legislation. - Unclear how the market would rule on an ambiguous "Board of Trade" arrangement if it were later codified via statute (unlikely per description language requiring formal ratification/CEA). - No Polymarket cross-check. # Calibration anchors - Kalshi current YES price: 15% (anchor). - Related Kalshi "any FTA" market: 38% — sets an upper bound context for China-specific pricing. - Base-rate/structural model estimate: ~0.5–2% (much lower than Kalshi's 15%, suggesting market may still be overpricing YES, or pricing in truce escalation into something formal). - Precedent: only 1 congressionally-ratified FTA (USMCA) since 2011; zero FTAs ever with a large non-market economy.

1. Both forecasts converge tightly (7% and 6%) well below the Kalshi anchor of 15% but neither explains why the market itself might still assign 15%—e.g., possible residual uncertainty about how "Board of Trade" legislation could be loosely interpreted, or optionality value in a ~3-year window with an unpredictable Trump administration; simply asserting "market overprices" without addressing why sophisticated traders haven't already arbitraged this gap is a gap in both rationales. 2. Neither forecast grapples with the tail scenario where Trump, motivated by dealmaking incentives and having already shown willingness to negotiate truces (Busan, Beijing visit), could push a narrow sectoral CEA (e.g., a "Board of Trade" statute) through a GOP-controlled Congress via reconciliation-like mechanisms or fast-track authority — this is a low-probability but distinct pathway not fully explored beyond dismissing the $30B concept as "narrow." 3. Both anchor heavily on the "zero precedent for FTA with non-market economy" base rate, but this reference class is thin (essentially N/A rather than a true zero-probability event) and could be seen as overweighted given unprecedented executive dealmaking style in Trump's second term — the brief itself flags "no evidence of intent" rather than "explicit rejection," which is weaker evidence than treated. 4. The two forecasts are nearly identical in both number and reasoning (7% vs 6%), suggesting insufficient independent variation — neither explores the wide range implied by the code_execution model itself (0.5%–15% depending on interpretation), and both collapse to the strict low end without acknowledging the meaningful probability mass Kalshi and the model's upper bound assign to looser resolution interpretations. 5. Neither rationale addresses the cross-market signal that the general "any FTA" market sits at 38% while China-specific is 15% — this 23-point gap could be probed further to check if the specific 15% has structural support beyond just "harder case," e.g., liquidity/volume risk (only ~108 contracts/day) could mean the 15% price is stale or thinly traded and not fully efficient, which both forecasts under-scrutinize before undercutting it. 6. Both forecasts treat the 3-year remaining window (through Jan 2029) as roughly static, but they underweight the possibility of a second-term "legacy deal" push in 2027-2028 as Trump seeks a signature achievement before leaving office, which historically has driven surprise diplomatic pivots (e.g., Nixon-China dynamic) — this scenario deserves at least a mention even if ultimately assigned low weight.

8% (73% confidence)

Yes: 8% No: 92%

The resolution bar — an FTA enacted via Senate ratification or a Congressional-Executive Agreement with implementing legislation — is far higher than anything US-China trade policy has approached; Phase One was deliberately kept executive-only, Section 301/IEEPA tariffs remain entrenched, and Congress is moving to restrict rather than liberalize China trade (S.3566). The Busan truce is a one-year tactical arrangement and the ~$30B 'Board of Trade' concept is narrow and not headed for statute, so the pathways to YES require both a dramatic diplomatic pivot and a legislative vehicle that no one is currently building. I stay below the 15% Kalshi anchor because the market is thinly traded (~108 contracts/day), has already fallen from 43%, and likely embeds some loose-interpretation optionality that the strict rules exclude. But per the critique I don't collapse to the 0.5–2% structural floor: a nearly three-year window, an unpredictable dealmaker seeking a legacy achievement, and genuine ambiguity about how a codified sectoral arrangement would resolve justify keeping meaningful tail mass, so I land at 8% YES.

Total pipeline time: 268.9s